3 Lifesciences Firms that are Overcoming Unique Challenges
3 Lifesciences Firms that are Overcoming Unique Challenges By The Lifesciences Magazine INTRODUCTION J.P. Morgan’s Life Sciences bankers are contributing to the success of cutting-edge enterprises of all stages, from start-ups to businesses on the verge of commercialization. Discover how three very distinct lifesciences firms industry are achieving growth while operating in an FDA regulatory climate that is becoming more difficult. Here are 3 Lifesciences Firms that are Overcoming Unique Challenges; 1. Amring Amring Medications is a privately owned firm that began operations in 2015 with the goal of developing, manufacturing, and marketing generic pharmaceuticals for specialized markets. Amring is a partner with a network of multinational biopharmaceutical businesses and has its headquarters in Berwyn, Pennsylvania, which is located just outside of Philadelphia. Despite the fact that Amring is a young company, it generated more than $30 million in revenue in 2016, and it is now p...